Global Insulin Pumps (External) Market Size By Type (Tethered pumps, Disposable/Patch pumps), By Application (Hospital, Clinic), By Region, And Segment Forecasts, 2023 to 2032

The Global Insulin Pumps (External) Market was valued at USD 4.9 billion in 2023 and is projected to reach USD 11.6 billion by 2031, growing at a CAGR of 11.3% during the forecast period from 2023 to 2031. The market is experiencing robust growth due to the increasing prevalence of diabetes worldwide, rising patient preference for minimally invasive and continuous insulin delivery solutions, and technological innovations such as tubeless and smart insulin pumps. As the diabetic population grows and awareness about insulin management improves, external insulin pumps are becoming a preferred solution for long-term blood glucose regulation.

Drivers:

1. Rising Global Diabetes Prevalence

The increasing incidence of type 1 and type 2 diabetes is significantly driving demand for external insulin pumps. According to the International Diabetes Federation, over 540 million adults were living with diabetes in 2023, a figure expected to rise substantially, boosting demand for automated insulin delivery systems.

2. Technological Advancements in Insulin Pumps

Innovation in insulin pump designs—including Bluetooth-enabled smart pumps, integration with Continuous Glucose Monitoring (CGM) systems, and smartphone-controlled devices—is revolutionizing diabetes management. These features enhance user convenience, compliance, and better glycemic control.

3. Patient-Centric Healthcare and Home-Based Therapies

As healthcare systems emphasize chronic disease management at home, the demand for portable and user-friendly insulin pumps is rising. Home-based therapy adoption, especially among the elderly diabetic population, is a significant growth contributor.

Restraints:

1. High Cost of Devices and Consumables

The initial acquisition and ongoing maintenance costs (such as reservoirs, infusion sets, and batteries) of external insulin pumps are substantial, often limiting accessibility in low- and middle-income regions.

2. Risk of Device Malfunctions and User Error

Although insulin pumps are reliable, concerns around device failure, incorrect dosage delivery, and improper usage by untrained patients may hinder adoption.

Opportunity:

1. Expansion in Emerging Markets

Rapid healthcare infrastructure development and rising diabetes awareness in Asia-Pacific and Latin America present untapped opportunities for insulin pump manufacturers.

2. Integration with AI and Predictive Analytics

The incorporation of artificial intelligence and data analytics to predict insulin needs, prevent hypoglycemia, and enhance personalized treatment represents a major leap in next-generation insulin pump technologies.

Market by System Type Insights:

The market is segmented into Tethered (Tubed) Pumps and Tubeless (Patch) Pumps. In 2023, Tethered Pumps held the largest market share due to their established clinical track record and insurance coverage advantages. However, the Tubeless Pump segment is expected to witness the highest CAGR, driven by patient preference for discretion, comfort, and ease of use.

Market by End-use Insights:

Hospitals dominated the end-use segment in 2023 due to the need for professional monitoring during insulin initiation and pump calibration. However, the Home Care Settings segment is anticipated to grow fastest, fueled by increased patient autonomy, advancements in remote monitoring technologies, and reimbursement policy support for at-home diabetes management.

Market by Regional Insights:

North America led the global market in 2023, owing to high diabetes prevalence, favorable reimbursement policies, and strong technological adoption. Asia-Pacific is projected to be the fastest-growing region during the forecast period, driven by an expanding diabetic population, growing healthcare expenditure, and government-led diabetes management initiatives in countries like India and China.

Competitive Scenario:

Key players in the market include Medtronic plc, Insulet Corporation, Tandem Diabetes Care, Inc., Roche Diabetes Care, Ypsomed AG, SOOIL Development Co. Ltd., Nipro Corporation, and Debiotech S.A. These companies are focusing on innovations such as closed-loop systems, strategic partnerships with healthcare providers, and expansion into untapped markets.

Recent Developments:

In 2024, Tandem Diabetes Care launched its mobile app-controlled insulin pump with CGM integration, receiving widespread acclaim for user-centered features.

Insulet Corporation expanded its Omnipod DASH system in the Asia-Pacific market through strategic distribution partnerships.

Medtronic plc announced its next-generation hybrid closed-loop system in 2023, enhancing automation and patient outcomes.

Scope of Work – Global Insulin Pumps (External) Market

Report Metric Details

Market Size (2023) USD 4.9 billion

Projected Market Size (2031) USD 11.6 billion

CAGR (2023–2031) 11.3%

Market Segments By System Type (Tethered, Tubeless), By End-use (Hospitals, Home Care)

Growth Drivers Rising diabetes prevalence, technological innovations

Opportunities AI-based pumps, growth in emerging markets

Key Market Developments:

2023: Medtronic launched a Bluetooth-enabled MiniMed system with predictive analytics for insulin delivery.

2024: Ypsomed AG entered into a partnership with a U.S.-based telehealth company to integrate insulin pump data into virtual care platforms.

2025: Insulet filed for regulatory approval of its fully automated insulin delivery system in European markets.

FAQs:

What is the current market size of the Global Insulin Pumps (External) Market?

The market was valued at USD 4.9 billion in 2023.

What is the major growth driver of the Global Insulin Pumps (External) Market?

Rising global diabetes prevalence and demand for advanced, minimally invasive insulin delivery systems.

Which is the largest region during the forecast period in the Global Insulin Pumps (External) Market?

North America leads the market due to high adoption of advanced technologies and robust healthcare systems.

Which segment accounted for the largest market share in the Global Insulin Pumps (External) Market?

Tethered Pumps held the largest market share in 2023.

Who are the key market players in the Global Insulin Pumps (External) Market?

Medtronic plc, Insulet Corporation, Tandem Diabetes Care, Roche Diabetes Care, Ypsomed AG, and SOOIL Development Co. Ltd. are among the leading players.